Tryton Medical, Inc. Announces Nordic-Baltic Dedicated Bifurcation Trial Studying the Tryton Side Branch Stent
5/23/2013 10:23:08 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PARIS--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton Side Branch Stent. The trial is a prospective, controlled, randomized, multicenter clinical study examining the role of final kissing balloon inflations in patient outcomes. A total of 150 patients will receive the Tryton Side Branch Stent with a drug-eluting stent, with evaluation by intravascular Optical Coherence Tomography (OCT) imaging technology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by